脂质体颗粒动力学和内微分布:对增强的透性和保留效应的定量重新评估
Yifan Cai1, Zichen Zhang1, Yi Lu2
1School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery of MOE and National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai 201203, China.
概括
这项研究表明,脂质体在瘤中积累的最小,大多数被肝脏和脏隔离. 微分布,而不是瘤总积累,更好地表明纳米载体透效率.
科学领域:
- 纳米医学是一种纳米医学.
- 癌症研究 癌症研究
- 药理动力学 药理动力学
背景情况:
- 增强的透性和保留 (EPR) 效应对于癌症纳米医学至关重要,但在显微镜层面上了解得很少.
- 目前对纳米载体传递的理解依赖于宏观解释,限制了对内动态的洞察力.
研究的目的:
- 直接比较脂肪体载体的瘤内行为及其药物有效载荷 (doxorubicin) 使用先进的跟踪.
- 从显微镜角度重新评估增强的透性和保留 (EPR) 效应.
主要方法:
- 使用第二个近红外 (NIR-II) 聚合引起的冷却 (ACQ) 探测器 (ACQ5) 在体内跟踪多克索鲁比载入的脂质体.
- 定量分析了脂质体和多克索鲁比辛的分布,区分了血管内和血管外的信号.
主要成果:
- 脂质体通过单核细胞系统 (肝脏和脏) 显示出显著的分离.
- 脂质体的瘤积累是适度的 (在24小时内约4%的ID/g).
- 观察到一种空间分离:脂质体透到瘤间隙,但多克索鲁比局部化到周围血管区域.
结论:
- 微分布是纳米载体透效率的更有意义的指标,而不是瘤总积累.
- 经典的宏观级EPR概念要求微观重新评估,以开发有效的纳米载体.
- 更好地了解内药理动力学对于下一代纳米药物开发至关重要.
更多相关视频
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
290
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
290
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Modified-Release Drug Delivery Systems: Bioavailability
60
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
60
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
69
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
69
Factors Affecting Drug Distribution: Organ Perfusion Rate
697
Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...
Perfusion rate-limited distribution relies on the...
697
Factors Affecting Drug Distribution: Tissue Permeability
767
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
767


